Small Business Stock Gain Exclusion Receives 2014 Extension
It’s not like the government to bring everyone some well-needed Christmas cheer, but the new tax bill that lawmakers were finally able to pass brought some good news for many investors before the year ends. It’s unfortunate that it took the entire year to get it done, but at least the tax provisions that did get extended will be good for the entire tax year of 2014.
One important extension affected the small business stock gain exclusion. The new act signed this last week extended the 100% exclusion for small business stock acquired in 2014. That means if the individual shareholder holds the qualified small business stock for five years, they can exclude up to the first $10 million of capital gain for Federal purposes, instead of having to hold it for 10 years before doing so. The exclusion even applies for both regular tax and the Alternative Minimum Tax (ATM).
It’s important to note that for now this extension is only good for the year 2014 and does not apply to next year’s taxes, however, Congress could vote to extend it again next year, as well. If you would like to learn about the Sec. 1202 Small Business Stock Gain, and how it works, then just click here for a detailed explanation. And feel free to contact us at GROCO with any of your tax questions by clicking here.
Hope For America | Bob Bennett
About Bob Bennett Former Senator Bob Bennett is the chairman of Bennett Group International, a private business and governmental consulting group he founded after leaving government service in 2011. As a U.S. Senator from Utah, he was a senior member of the Senate Banking Committee and a member of the distinguished Joint Economic Committee.…
Are You Ready For Retirement? | Jason Greenwood
About Jason Greenwood In 1999 Jason started his career in the financial services industry. While at Fidelity Investments he learned the importance of diversification and how to trade effectively. As an options trader for Client Services he became adept in the stock and derivatives markets. Desiring to become more involved with clients portfolios, Jason…
The Science of Immunology | Dr. Benjamin Chen
About Dr. Benjamin Chen Dr. Benjamin Chen is the CEO and Chairman of Immune Targeting Systems (ITS), a company in the field of Immunology which is dedicating to creating vaccines for viral infections. During his career Dr. Chen has worked as a scientist, banker and entrepreneur. In addition to his duties at ITS he…
The Servant Leader | Michael Gibbons
About Michael Gibbons Michael Gibbons is the director of student support and an adjunct instructor of family and child development at Southern Virginia University. He has held that position since August of 2003 and also teaches courses in family and child development and in social and behavioral sciences. His BS degree is in developmental…